Table 2 Effect of low molecular heparin prophylaxis on the thrombelastography between the two patient groups at different time points

R (mm)

  Before

5.68 ± 0.92

5.86 ± 1.03

5.78 ± 0.98

0.4830

  Day1

5.30 ± 1.04

5.63 ± 1.32

5.47 ± 1.20

0.1586

  Day4

5.25 ± 0.98

5.56 ± 1.04

5.41 ± 1.02

0.1886

  Day9

5.32 ± 1.12

5.68 ± 1.19

5.52 ± 1.17

0.1255

K (mm)

  Before

1.90 ± 0.78

1.80 ± 0.39

1.85 ± 0.59

0.3866

  Day1

1.61 ± 0.41

1.79 ± 0.54

1.71 ± 0.49

0.0847

  Day4

1.35 ± 0.36

1.40 ± 0.34

1.38 ± 0.35

0.6934

  Day9

1.30 ± 0.65

1.25 ± 0.35

1.28 ± 0.50

0.6763

MA (mm)

  Before

61.15 ± 6.00

62.00 ± 5.34

61.63 ± 5.61

0.5607

  Day1

63.20 ± 5.29

61.41 ± 4.50

62.27 ± 4.95

0.1658

  Day4

66.81 ± 7.31

66.33 ± 6.23

66.55 ± 6.73

0.7103

  Day9

69.35 ± 6.48

69.14 ± 6.84

69.24 ± 6.64

0.8783

α-angle

  Before

67.76 ± 5.57

67.79 ± 5.17

67.78 ± 5.31

0.9784

  Day1

69.13 ± 5.72

67.63 ± 6.64

68.34 ± 6.23

0.1844

  Day4

72.15 ± 5.62

72.23 ± 3.85

72.19 ± 4.75

0.9450

  Day9

74.06 ± 4.89

73.66 ± 4.65

73.84 ± 4.74

0.7273

CI

  Before

0.42 ± 1.76

0.46 ± 1.34

0.44 ± 1.53

0.9251

  Day1

1.12 ± 1.58

0.45 ± 1.89

0.77 ± 1.77

0.0455

  Day4

1.94 ± 1.54

1.67 ± 1.26

1.80 ± 1.40

0.4236

  Day9

2.23 ± 1.73

2.09 ± 1.52

2.15 ± 1.61

0.6695